We are monitoring the impact of COVID-19 on North America Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 624
Share on
Share on

North America Vaccine Adjuvant Market Research Report – Segmented By Type, By Route Of Administration, By Mechanism Of Action And By Country (US, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 624
Pages: 145

North America Vaccine Adjuvant market size (2021 to 2026)

The size of the Vaccine Adjuvant Market in North America is estimated to be growing at a CAGR of 10.3% from 2021 to 2026. The market is estimated to be worth USD 354.7 million by 2026 and USD 217.3 million in 2021. 

North America is dominating the adjuvant vaccine market globally. Growth in the North American segment is mainly driven by the fast-increasing elderly population and rising government funding in North American countries.

Vaccine adjuvants benefit in improving novel and advanced vaccines, which was not probable earlier due to less effectiveness of a vaccine using the only antigen. Adjuvants are progressively used to advance harmless and effective vaccines as they create healthy, long-lasting defensive immune responses with a high edge of safety against infections. 

This market is primarily driven by the increasing prevalence of diseases such as allergy, cancer, and HIV/AIDS, rising demand for innovative treatment options, and improvement of enhanced vaccine immunization. In addition, the upsurge in alliances and acquisitions by private organizations and augmented funding by government bodies for research and development are also expected to drive market growth.

The primary factor hindering the growth of the North American adjuvant vaccine market is stringent regulation for new vaccines.

This research report on the North American vaccine adjuvant market has been segmented and sub-segmented into the following categories:

By Type: 

  • Aluminum Salts
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Bacteria Derived Adjuvants
  • Liposome Adjuvants
  • Carbohydrate Adjuvants

By Route Of Administration: 

  • Oral
  • Intradermal
  • Subcutaneous
  • Intranasal
  • Intramuscular

By Mechanism Of Action: 

  • Immune Stimulants
  • Carriers
  • Vehicle Adjuvants

By Country: 

  • The United States
  • Canada
  • The Rest of North America

Regionally, the USA led the North American region due to increasing awareness regarding vaccines, followed by Canada.

The U.S. vaccine adjuvant market is driven by the continued use of aluminum salt vaccine adjuvant for the last three decades in the market. In 2019, the National Institute of Infectious Allergy and Infectious Diseases had taken the initiative to develop advanced vaccine adjuvant for the better use of tuberculosis and non-HIV infectious disease in the United States. The presence of prominent critical players in this region is influencing the growth of the market. The high prevalence of chronic and acute disorders in the US is propelling the growth of the adjuvant vaccine market. Recently, private and government funding collaboration to develop innovative vaccine adjuvants to combat viruses will boost the market.

The Canadian vaccine adjuvant market is anticipated to grow at a robust CAGR during the forecast period in the North American market. The Canadian government has more funding to develop an immune response and immune safety in this pandemic situation. There are 2561 HIV diagnoses in Canada, with an increasing rate of 8.2% compared to the previous year. Also, the rising prevalence of cancer and infectious disease in the region is estimated to drive the Canadian vaccine adjuvant market further. The presence of healthcare facilities and innovation in drug discovery is fuelling the growth of the Canadian vaccine adjuvant market.

KEY MARKET PLAYERS:

Companies playing a dominant role in the North America vaccine adjuvant market profiled in this report are MPV Technologies, Avanti Polar Lipids, Novavax Inc. Brenntag Biosector, SEPPIC, Agenus, Inc., Invivogen, SPI Pharma, Inc., CSL Limited, and OZ Biosciences.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Vaccine Adjuvant Market, By Region, From 2021 to 2026 (USD Million)
  2. North America Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  3. North America Aluminium Salts Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Tensoactive Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Adjuvant Emulsions Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Bacteria derived Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Liposome Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Carbohydrate Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Vaccine Adjuvant Market, By Route of Administration , From 2021 to 2026 (USD Million)
  10. North America Oral Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Intradermal Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Subcutaneous Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Intranasal Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Intramuscular Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  16. North America Immuno Stimulants Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Carriers Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Vehicle Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  19. United States Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  20. United States Vaccine Adjuvant Market, By Route of Administration , From 2021 to 2026 (USD Million)
  21. United States Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  22. Canada Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  23. Canada Vaccine Adjuvant Market, By Route of Administration , From 2021 to 2026 (USD Million)
  24. Canada Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample